| scholarly article | Q13442814 |
| review article | Q7318358 |
| P50 | author | Scott B Halstead | Q60059357 |
| P921 | main subject | antibody | Q79460 |
| macrophage | Q184204 | ||
| pathogenesis | Q372016 | ||
| Dengue virus | Q476209 | ||
| P304 | page(s) | S830-9 | |
| P577 | publication date | 1989-05-01 | |
| P1433 | published in | Reviews of Infectious Diseases | Q24091437 |
| P1476 | title | Antibody, macrophages, dengue virus infection, shock, and hemorrhage: a pathogenetic cascade | |
| P478 | volume | 11 Suppl 4 |
| Q27490166 | A Prospective Nested Case-Control Study of Dengue in Infants: Rethinking and Refining the Antibody-Dependent Enhancement Dengue Hemorrhagic Fever Model |
| Q35011189 | A birth cohort study of viral infections in Vietnamese infants and children: study design, methods and characteristics of the cohort |
| Q40778595 | A review of feline infectious peritonitis virus: molecular biology, immunopathogenesis, clinical aspects, and vaccination |
| Q37443026 | A shorter time interval between first and second dengue infections is associated with protection from clinical illness in a school-based cohort in Thailand |
| Q27480826 | Activation of endothelial cells via antibody-enhanced dengue virus infection of peripheral blood monocytes |
| Q33965959 | An antigen capture enzyme-linked immunosorbent assay reveals high levels of the dengue virus protein NS1 in the sera of infected patients |
| Q37987131 | Animal models of dengue virus infection |
| Q40344535 | Antibody prophylaxis and therapy against West Nile virus infection in wild-type and immunodeficient mice |
| Q35567408 | B-cell responses during primary and secondary dengue virus infections in humans |
| Q42991886 | Barriers to preclinical investigations of anti-dengue immunity and dengue pathogenesis |
| Q27480369 | Both Virus and Tumor Necrosis Factor Alpha Are Critical for Endothelium Damage in a Mouse Model of Dengue Virus-Induced Hemorrhage |
| Q40039408 | Bovine Lactoferrin Inhibits Dengue Virus Infectivity by Interacting with Heparan Sulfate, Low-Density Lipoprotein Receptor, and DC-SIGN. |
| Q54238236 | Challenges in dengue research: A computational perspective. |
| Q27469691 | Chimeric yellow fever/dengue virus as a candidate dengue vaccine: quantitation of the dengue virus-specific CD8 T-cell response |
| Q57100423 | Circulating dengue virus serotypes in Bangladesh from 2013 to 2016 |
| Q27487953 | Closing the door on flaviviruses: Entry as a target for antiviral drug design |
| Q27485131 | Complement Protein C1q Inhibits Antibody-Dependent Enhancement of Flavivirus Infection in an IgG Subclass-Specific Manner |
| Q35814043 | Conserved MHC class I-presented dengue virus epitopes identified by immunoproteomics analysis are targets for cross-serotype reactive T-cell response |
| Q27469921 | Construction, safety, and immunogenicity in nonhuman primates of a chimeric yellow fever-dengue virus tetravalent vaccine |
| Q92988061 | Contemporary Strategies and Current Trends in Designing Antiviral Drugs against Dengue Fever via Targeting Host-Based Approaches |
| Q34700783 | Current perspectives on the spread of dengue in India |
| Q35761395 | Delayed antibody dependent enhancement of low passage dengue virus 4 isolates |
| Q27480760 | Demonstration of binding of dengue virus envelope protein to target cells |
| Q24536024 | Dendritic-cell-specific ICAM3-grabbing non-integrin is essential for the productive infection of human dendritic cells by mosquito-cell-derived dengue viruses |
| Q37358169 | Dengue 2 infection of HepG2 liver cells results in endoplasmic reticulum stress and induction of multiple pathways of cell death |
| Q27481475 | Dengue Virus (DV) Replication in Monocyte-Derived Macrophages Is Not Affected by Tumor Necrosis Factor Alpha (TNF- ), and DV Infection Induces Altered Responsiveness to TNF- Stimulation |
| Q27490477 | Dengue Virus Infection Induces Upregulation of GRP78, Which Acts To Chaperone Viral Antigen Production |
| Q36280060 | Dengue Virus-Induced Inflammation of the Endothelium and the Potential Roles of Sphingosine Kinase-1 and MicroRNAs. |
| Q35739855 | Dengue hemorrhagic fever-associated immunomediators induced via maturation of dengue virus nonstructural 4B protein in monocytes modulate endothelial cell adhesion molecules and human microvascular endothelial cells permeability |
| Q28542607 | Dengue therapeutics, chemoprophylaxis, and allied tools: state of the art and future directions |
| Q34766895 | Dengue virus activates membrane TRAIL relocalization and IFN-α production by human plasmacytoid dendritic cells in vitro and in vivo. |
| Q54216769 | Dengue virus induces increased activity of the complement alternative pathway in infected cells. |
| Q21142740 | Dengue virus infection and virus-specific HLA-A2 restricted immune responses in humanized NOD-scid IL2rgammanull mice |
| Q27470758 | Dengue virus nonstructural protein NS5 induces interleukin-8 transcription and secretion |
| Q27480811 | Dengue virus replication in human hepatoma cells activates NF-kappaB which in turn induces apoptotic cell death |
| Q24673736 | Dengue virus selectively induces human mast cell chemokine production |
| Q24609884 | Dengue: defining protective versus pathologic immunity |
| Q29619739 | Dengue: the risk to developed and developing countries |
| Q35043859 | Describing the breakbone fever: IDODEN, an ontology for dengue fever |
| Q35081258 | Detection of serotype-specific antibodies to the four dengue viruses using an immune complex binding (ICB) ELISA |
| Q27477546 | Differential Enhancement of Dengue Virus Immune Complex Infectivity Mediated by Signaling-Competent and Signaling-Incompetent Human Fc RIA (CD64) or Fc RIIA (CD32) |
| Q33402687 | Effects of short-course oral corticosteroid therapy in early dengue infection in Vietnamese patients: a randomized, placebo-controlled trial |
| Q33954396 | Elevated levels of full-length and thrombin-cleaved osteopontin during acute dengue virus infection are associated with coagulation abnormalities. |
| Q27485633 | Elevated levels of soluble ST2 protein in dengue virus infected patients |
| Q33430347 | Elevated levels of vascular endothelial growth factor in adults with severe dengue infection |
| Q27473433 | Enzyme-linked immunosorbent assay specific to Dengue virus type 1 nonstructural protein NS1 reveals circulation of the antigen in the blood during the acute phase of disease in patients experiencing primary or secondary infections |
| Q33428741 | Epidemiology of Dengue Among Children Aged < 18 Months-Puerto Rico, 1999-2011. |
| Q34354805 | Evaluation of nonstructural 1 antigen assays for the diagnosis and surveillance of dengue in Singapore |
| Q39565102 | Evolution of attenuating mutations in dengue-2 strain S16803 PDK50 vaccine and comparison of growth kinetics with parent virus |
| Q36236428 | Fcγ-receptor IIa-mediated Src Signaling Pathway Is Essential for the Antibody-Dependent Enhancement of Ebola Virus Infection |
| Q34179923 | Flavivirus NS4A-induced autophagy protects cells against death and enhances virus replication |
| Q92416661 | Genetic risk for dengue hemorrhagic fever and dengue fever in multiple ancestries |
| Q34051846 | Heterologous immunity between viruses |
| Q34159981 | Heterologous immunity: immunopathology, autoimmunity and protection during viral infections. |
| Q27481682 | High Pro-Inflammatory Cytokine Secretion and Loss of High Avidity Cross-Reactive Cytotoxic T-Cells during the Course of Secondary Dengue Virus Infection |
| Q27485240 | Higher Infection of Dengue Virus Serotype 2 in Human Monocytes of Patients with G6PD Deficiency |
| Q56000966 | Human Serum With High Neutralizing Antibody Titers Against Both Zika and Dengue Virus Shows Delayed In Vitro Antibody-Dependent Enhancement of Dengue Virus Infection |
| Q27469896 | Human dendritic cells are activated by dengue virus infection: enhancement by gamma interferon and implications for disease pathogenesis |
| Q27488243 | Humoral Immune Responses of Dengue Fever Patients Using Epitope-Specific Serotype-2 Virus-Like Particle Antigens |
| Q27480380 | Identification of amino acids involved in recognition by dengue virus NS3-specific, HLA-DR15-restricted cytotoxic CD4+ T-cell clones |
| Q27489404 | Immunization with Heterologous Flaviviruses Protective Against Fatal West Nile Encephalitis |
| Q38000488 | Immunological memory ≠ protective immunity |
| Q36843481 | Impact of renal failure on the outcome of dengue viral infection |
| Q40061235 | Induction of Osteopontin by Dengue Virus-3 Infection in THP-1 Cells: Inhibition of the Synthesis by Brefelamide and Its Derivative. |
| Q27469687 | Infection of human cells by dengue virus is modulated by different cell types and viral strains |
| Q27469710 | Infection of primary cultures of human Kupffer cells by Dengue virus: no viral progeny synthesis, but cytokine production is evident. |
| Q30833371 | Inflammatory mediators in dengue virus infection in children: interleukin-8 and its relationship to neutrophil degranulation |
| Q28478179 | Inhibition of dengue virus entry and multiplication into monocytes using RNA interference |
| Q37421281 | Intermedin/adrenomedullin-2 is a hypoxia-induced endothelial peptide that stabilizes pulmonary microvascular permeability. |
| Q37640590 | Involvement of fatty acid synthase in dengue virus infection |
| Q64126210 | Largest dengue outbreak of the decade with high fatality may be due to reemergence of DEN-3 serotype in Dhaka, Bangladesh, necessitating immediate public health attention |
| Q36396156 | Liposome-mediated delivery of iminosugars enhances efficacy against dengue virus in vivo |
| Q24289053 | Localization and Characterization of Flavivirus Envelope Glycoprotein Cross-Reactive Epitopes |
| Q27787379 | Low sensitivity of the tourniquet test for differential diagnosis of dengue: an analysis of 28,000 trials in patients |
| Q33623456 | Lung in dengue: computed tomography findings |
| Q26861223 | Macrophage heterogeneity in tissues: phenotypic diversity and functions |
| Q28236244 | Manipulation of cell surface macromolecules by flaviviruses |
| Q35097469 | Maternal antibody and viral factors in the pathogenesis of dengue virus in infants |
| Q24570135 | Maturation of dengue virus nonstructural protein 4B in monocytes enhances production of dengue hemorrhagic fever-associated chemokines and cytokines |
| Q27469591 | Modulation of Dengue virus infection in human cells by alpha, beta, and gamma interferons. |
| Q27480738 | Multiple specificities in the murine CD4+ and CD8+ T-cell response to dengue virus |
| Q40352062 | Non-invasive diagnosis of risk in dengue patients using bioelectrical impedance analysis and artificial neural network. |
| Q40610405 | Participation of the Dengue virus in the fibrinolytic process |
| Q36844707 | Pathogenic epitopes, heterologous immunity and vaccine design |
| Q35152094 | Potent dengue virus neutralization by a therapeutic antibody with low monovalent affinity requires bivalent engagement |
| Q27480808 | Pre- and postexposure protection by passive immunoglobulin but no enhancement of infection with a flavivirus in a mouse model |
| Q38998237 | Precise location of sequential dengue virus subcomplex and complex B cell epitopes on the nonstructural-1 glycoprotein |
| Q27485010 | Primary Human Splenic Macrophages, but Not T or B Cells, Are the Principal Target Cells for Dengue Virus Infection In Vitro |
| Q40037808 | Prior Exposure to Zika Virus Significantly Enhances Peak Dengue-2 Viremia in Rhesus Macaques |
| Q27489893 | Progress on the development of therapeutics against West Nile virus |
| Q34212157 | RNA interference mediated inhibition of dengue virus multiplication and entry in HepG2 cells |
| Q36992653 | Re-evaluation of the pathogenic roles of nonstructural protein 1 and its antibodies during dengue virus infection |
| Q93061315 | Reassessing therapeutic antibodies for neglected and tropical diseases |
| Q56960671 | Recent Developments in Recombinant Protein-Based Dengue Vaccines |
| Q27469664 | Recombinant chimeric yellow fever-dengue type 2 virus is immunogenic and protective in nonhuman primates |
| Q27469685 | Release of vasoactive cytokines by antibody-enhanced dengue virus infection of a human mast cell/basophil line |
| Q39626461 | Retinoic acid inducible gene-I and melanoma differentiation-associated gene 5 are induced but not essential for dengue virus induced type I interferon response |
| Q36795668 | Role of T-cell epitope-based vaccine in prophylactic and therapeutic applications |
| Q35183147 | SHP-1-dependent macrophage differentiation exacerbates virus-induced myositis |
| Q36382589 | Sculpting humoral immunity through dengue vaccination to enhance protective immunity |
| Q34500818 | Serum proteome and cytokine analysis in a longitudinal cohort of adults with primary dengue infection reveals predictive markers of DHF. |
| Q66679939 | Simultaneous Coinfection of Macaques with Zika and Dengue Viruses Does not Enhance Acute Plasma Viremia but Leads to Activation of Monocyte Subsets and Biphasic Release of Pro-inflammatory Cytokines |
| Q34120070 | Structure and function analysis of therapeutic monoclonal antibodies against dengue virus type 2. |
| Q27469587 | Study of Dengue virus infection in SCID mice engrafted with human K562 cells. |
| Q33414560 | Subversion of early innate antiviral responses during antibody-dependent enhancement of Dengue virus infection induces severe disease in immunocompetent mice |
| Q40665181 | Syndromes with renal failure and shock |
| Q27485295 | TRAIL Is a Novel Antiviral Protein against Dengue Virus |
| Q35594746 | The burden of dengue and chikungunya worldwide: implications for the southern United States and California |
| Q36978907 | The cytokine response of U937-derived macrophages infected through antibody-dependent enhancement of dengue virus disrupts cell apical-junction complexes and increases vascular permeability |
| Q27477510 | The four serotypes of dengue recognize the same putative receptors in Aedes aegypti midgut and Ae. albopictus cells |
| Q90020206 | The journey of Zika to the developing brain |
| Q38284671 | The relevance of dengue virus genotypes surveillance at country level before vaccine approval |
| Q37713190 | The role of endothelial activation in dengue hemorrhagic fever and hantavirus pulmonary syndrome |
| Q27011587 | Understanding the dengue viruses and progress towards their control |
| Q65054977 | Using Macaques to Address Critical Questions in Zika Virus Research. |
| Q36213311 | Variation in inflammatory/regulatory cytokines in secondary, tertiary, and quaternary challenges with dengue virus |
| Q37181382 | Vascular endothelium: the battlefield of dengue viruses |
| Q64889951 | Zika Virus Induced More Severe Inflammatory Response Than Dengue Virus in Chicken Embryonic Livers. |
| Q28004378 | Zika Virus RNA Replication and Persistence in Brain and Placental Tissue |
| Q55645060 | Zika convalescent macaques display delayed induction of anmanestic cross-neutralizing antibody responses after dengue infection. |
| Q26336601 | Zika virus productively infects primary human placenta-specific macrophages |
Search more.